Evidence map›Paper›PMID 33957008›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2021

A N-Terminus Domain Determines Amelogenin's Stability to Guide the Development of Mouse Enamel Matrix.

Yulei Huang, Yushi Bai, Chih Chang, Margot Bacino, Ieong Cheng Cheng, Li Li, Stefan Habelitz, Wu Li, Yan Zhang

Open access · greenAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Amelogenin proteolysis orchestrates functional amyloid pathways in enamel development.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Article
  4. Amyloid-like amelogenin nanoribbons template mineralization via a low-energy interface of ion binding sites.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yulei HuangDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.
Yushi BaiGuangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun-Yat-sen University, Guangzhou, China.
Chih ChangDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.
Margot BacinoGuangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun-Yat-sen University, Guangzhou, China.
Ieong Cheng ChengDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.
Li LiDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.
Stefan HabelitzGuangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun-Yat-sen University, Guangzhou, China.
Wu LiDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.
Yan ZhangDepartment of Orofacial Sciences, University of California, San Francisco, CA, USA.ORCID 0000-0002-2373-1696
University of California, San Francisco · USSun Yat-sen University · CN

Funding

The stage-specific regulation of ameloblastin and enamelin by the distinct nuclear factorsR01DE027076 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Yan Zhang · 2017 to 2026
$4.0M
Amyloids in Enamel DevelopmentR01DE025709 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HABELITZ, STEFAN FRIEDRICH, LI, WU · 2016 to 2020
$3.3M
NIDCR NIH HHS R01 DE025709NIDCR NIH HHS R01 DE027076
6 · The paper itself

Abstract

Amelogenins, the principal proteins in the developing enamel microenvironment, self-assemble into supramolecular structures to govern the remodeling of a proteinaceous organic matrix into longitudinally ordered hydroxyapatite nanocrystal arrays. Extensive in vitro studies using purified native or recombinant proteins have revealed the potential of N-terminal amelogenin on protein self-assembly and its ability to guide the mineral deposition. We have previously identified a 14-aa domain (P2) of N-terminal amelogenin that can self-assemble into amyloid-like fibrils in vitro. Here, we investigated how this domain affects the ability of amelogenin self-assembling and stability of enamel matrix protein scaffolding in an in vivo animal model. Mice harboring mutant amelogenin lacking P2 domain had a hypoplastic, hypomineralized, and aprismatic enamel. In vitro, the mutant recombinant amelogenin without P2 had a reduced tendency to self-assemble and was prone to accelerated hydrolysis by MMP20, the prevailing metalloproteinase in early developing enamel matrix. A reduced amount of amelogenins and a lack of elongated fibrous assemblies in the development enamel matrix of mutant mice were evident compared with that in the wild-type mouse enamel matrix. Our study is the first to demonstrate that a subdomain (P2) at the N-terminus of amelogenin controls amelogenin's assembly into a transient protein scaffold that resists rapid proteolysis during enamel development in an animal model. Understanding the building blocks of fibrous scaffold that guides the longitudinal growth of hydroxyapatites in enamel matrix sheds light on protein-mediated enamel bioengineering. © 2021 American Society for Bone and Mineral Research (ASBMR).

Indexed as

AmelogenesisDental Enamel ProteinsAmelogeninAnimalsMiceProtein DomainsProteolysisRecombinant ProteinsAmelogeninDental Enamel ProteinsRecombinant ProteinsAMELOGENINAMYLOID-FORMING PEPTIDEENAMEL MATRIX FORMATIONMMP20 HYDROLYSISSCAFFOLD

Identifiers

PMID33957008
PMCPMC9307086
OpenAlexW3159223430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.